Search

everythinglearnresearchcommunity

for

Search:↓

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Nutritional supplements can help manage hair loss and promote hair growth by strengthening hair roots and countering harmful effects of pollution, smoking, and deficiencies in vitamins and minerals.

Tetrathiomolybdate reduces hair growth marker in skin cells by boosting harmful oxygen molecules, but effects can be reversed.

Nanotube-based hair treatments could improve hair health and growth, and offer long-lasting effects.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

PRP injections help with carpal tunnel symptoms short-term, but more research is needed for long-term effects.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

c-Myc activation in mouse skin increases sebaceous gland growth and affects hair follicle development.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Overexpression of COX-2 in mice skin causes abnormal skin and hair development.

ALRN-6924 may prevent hair loss caused by chemotherapy.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

New hair loss treatments could be improved by using combined biological markers.

Exosomes from different stem cell sources affect immune cells and brain cell growth differently.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Powered exoskeleton training improves body perception and quality of life in spinal cord injury patients.

Using A132 hair dye with sunlight can cause skin damage and hair loss.

Disrupted sleep patterns from artificial light can slow hair growth and may lead to hair loss.

Improving education, insurance, and support can help scarring alopecia patients access better care.